ASCOT Study confirms the benefit of new classes of hypotensive drugs

Tomasz Pasierski

Abstract

8/2005 vol. 8

ASCOT Study confirms the benefit of new classes of hypotensive drugs

Tomasz Pasierski

Przew Lek 2005; 8: 16-18

Online publish date: 2005/11/02

View full text

AMA

Pasierski T. ASCOT Study confirms the benefit of new classes of hypotensive drugs. Przewodnik Lekarza/Guide for GPs. 2005:16-18.

APA

Pasierski, T. (2005). ASCOT Study confirms the benefit of new classes of hypotensive drugs. Przewodnik Lekarza/Guide for GPs, 16-18.

Chicago

Pasierski, Tomasz. 2005. "ASCOT Study confirms the benefit of new classes of hypotensive drugs". Przewodnik Lekarza/Guide for GPs: 16-18.

Harvard

Pasierski, T. (2005). ASCOT Study confirms the benefit of new classes of hypotensive drugs. Przewodnik Lekarza/Guide for GPs, pp.16-18.

MLA

Pasierski, Tomasz. "ASCOT Study confirms the benefit of new classes of hypotensive drugs." Przewodnik Lekarza/Guide for GPs, 2005, pp. 16-18.

Vancouver

Pasierski T. ASCOT Study confirms the benefit of new classes of hypotensive drugs. Przewodnik Lekarza/Guide for GPs. 2005:16-18.

Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as re – quired, in the
Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet online, 4 September 2005.

Share

Integrated with